Clinical significance of IGF1R gene expression in patients with Stage II/III gastric cancer who receive curative surgery and adjuvant chemotherapy with S-1

Journal of Cancer Research and Clinical Oncology
Koji NumataMunetaka Masuda

Abstract

Curative resection and adjuvant chemotherapy is the standard treatment for Stage II/III gastric cancer, and S-1 is widely used for adjuvant chemotherapy. The type 1 insulin-like growth factor receptor (IGF1R) is involved in cell proliferation and prevention of apoptosis in many tumors. We evaluated the relative expression of the IGF1R gene to determine whether such expression correlates with outcomes in patients with Stage II/III gastric cancer. We measured the expression levels of the IGF1R gene in specimens of cancer and adjacent normal mucosa obtained from 134 patients with Stage II/III gastric cancer who received curative resection and adjuvant chemotherapy with S-1. We then evaluated whether the IGF1R gene expression levels correlate with clinicopathological characteristics and outcomes. IGF1R mRNA expression levels tended to be higher in cancer tissue than in the normal adjacent mucosa (P = 0.078). Multivariate analysis showed that high IGF1R gene expression was a significant independent predictor of poor survival in Stage II/III gastric cancer after curative resection and adjuvant chemotherapy with S-1 (HR 3.681, P = 0.007). The overall survival rate was significantly lower in patients with high IGF1R gene expression tha...Continue Reading

References

Mar 1, 1997·The Journal of Endocrinology·V A BlakesleyD LeRoith
Jun 24, 1997·Proceedings of the National Academy of Sciences of the United States of America·S KharbandaD Kufe
Apr 30, 1998·Current Opinion in Cell Biology·J Downward
Feb 18, 1999·Current Biology : CB·C BelhamJ Avruch
Jun 18, 2002·The Lancet Oncology·Gregor Fürstenberger, Hans-Jörg Senn
Feb 19, 2003·Statistics in Medicine·Madhu MazumdarJennifer Bacik
Nov 5, 2003·The Journal of Pathology·Kresimir PavelićJasminka Pavelić
Nov 6, 2007·The New England Journal of Medicine·Shinichi SakuramotoUNKNOWN ACTS-GC Group
Dec 15, 2007·The Journal of Investigative Dermatology·Caroline HilmiCorine Bertolotto
Feb 9, 2010·Journal of Cancer Research and Clinical Oncology·Alyse HopkinsJia-Lin Yang
Oct 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mitsuru SasakoYasuo Ohashi
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray

❮ Previous
Next ❯

Citations

Aug 17, 2018·International Journal of Molecular Sciences·Armando CeveniniEsther Imperlini
May 21, 2016·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Xiao YuMin Hao
Jun 1, 2016·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Xiao YuMin Hao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

© 2021 Meta ULC. All rights reserved